Clinical Trials Logo

Smoking Cessation clinical trials

View clinical trials related to Smoking Cessation.

Filter by:

NCT ID: NCT03927989 Completed - Smoking Cessation Clinical Trials

Tobacco Treatment in the Context of Lung Cancer Screening

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

The proposed study will test a medication plus text messaging intervention specifically designed for lung cancer screening patients. Half of the patients will receive standard of care, and half will receive the treatment intervention.

NCT ID: NCT03897439 Completed - Smoking Cessation Clinical Trials

Individualizing Pharmacotherapy for African American Smokers

Start date: May 1, 2019
Phase: Phase 3
Study type: Interventional

Improving cessation outcomes for African American smokers through the use of novel, empirically-based strategies is a national health priority. In the vast majority of smoking cessation studies and in clinical practice, when smokers are provided a medication to help them quit, they are expected to continue that medication regardless of how well it is working. This study will assess whether African Americans smokers respond better if they continue with a single treatment or if their treatment is changed when that treatment is not working.

NCT ID: NCT03885336 Completed - Smoking Cessation Clinical Trials

Couples Dynamics and Smoking Cessation

SCOR
Start date: August 26, 2018
Phase:
Study type: Observational

This study is about investigating smoking and attempts to quit smoking in couples. Participation will help determine better treatment efforts for couples who want to quit smoking. All study procedures will be conducted remotely, allowing couples to interact with study personnel through zoom.

NCT ID: NCT03870906 Completed - Smoking Cessation Clinical Trials

Smoking Cessation Programme in Workplaces in Hong Kong (Phase IV)

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Smoking causes cardiovascular and respiratory diseases, cancers and diabetes, and it has been a leading risk factor for death globally. Despite the availability of smoking cessation services locally, most smokers do not use such services. Workplace is one of the most convenient platforms to provide smoking cessation services and over 55% of smokers are employed according to the local population-based survey. However, the effectiveness of a smoking cessation programme conducted in workplace is yet to be examined in Hong Kong, and the attitudes and practices of corporations in promoting smoking cessation are not clear. Thus, this study aims to examine the employers'/ managerial staff's knowledge, attitudes and practices in promoting smoking cessation in workplace and evaluate the smoking behaviors of participants before and after attending a smoking cessation intervention.

NCT ID: NCT03870022 Completed - Smoking Cessation Clinical Trials

Pivot Breath Sensor Performance Study

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

A clinical study enrolling 70 subjects to: - evaluate the user performance of the Pivot Breath Sensor - compare measurements from the Pivot Breath Sensor to a similar device - assess user documentation comprehension - obtain feedback on the Pivot Breath Sensor via rating scales. No medical decisions will be made related to test results.

NCT ID: NCT03849092 Completed - Smoking Cessation Clinical Trials

Smoking Cessation: Financial Incentives

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The aim of this intervention is to test if the investigator, by offering a financial incentive to smokers who abstinence from smoking, can: 1. recruit more smokers with low socioeconomic status to municipal smoking cessation programs 2. achieve higher abstinence rates at municipal smoking cessation programs among citizens with low economic status - Rather than by use of campaigns (=usual strategy) informing citizens about their options for support at municipal smoking cessation programs?

NCT ID: NCT03848208 Completed - Smoking Cessation Clinical Trials

A Single Dose-escalation Study of Cytisine in Adult Smokers

Start date: February 28, 2019
Phase: Phase 1
Study type: Interventional

The objectives of this study are: 1. To assess the tolerability and safety of cytisine as a single oral dose. 2. To define the Cmax levels associated to the occurrence of dose-limiting adverse events.

NCT ID: NCT03841292 Completed - Smoking Cessation Clinical Trials

Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

The addition of tDCS as an adjunct to pharmacotherapy is a novel approach but one that is grounded in a growing evidence-base.The primary objective of this research is to provide preliminary evidence of the effectiveness of tDCS as an adjunct treatment to pharmacotherapy for smoking cessation. The investigators hypothesize that the addition of active tDCS to the left DLPFC will improve the effectiveness of varenicline as reflected by higher quit rates at end of treatment compared to the sham group. Smoking status will be biochemically confirmed at various time points using expired cotinine measures. Furthermore, the investigators will be collecting neuroimaging (fMRI) data as well as measures of attentional bias to explore the neurological and physiological correlates from using adjunct tDCS and varenicline therapy.

NCT ID: NCT03837379 Completed - Depression Clinical Trials

Goal2Quit + NRT Sampling

Start date: June 22, 2020
Phase: N/A
Study type: Interventional

The goal of this work is to develop, systematically evaluate, and clinically test an integrated cessation intervention comprised of a depression-specific Behavioral Activation (BA) for cessation mobile app ("Goal2Quit") packaged with nicotine replacement therapy (NRT) sampling. This integrated intervention will address the need for an easily disseminable, evidence-based, depression-specific cessation intervention for delivery via primary care.

NCT ID: NCT03836573 Completed - Smoking Cessation Clinical Trials

Feasibility of a Decision Aid for E-Cigarettes in Primary Care

Start date: March 6, 2019
Phase: N/A
Study type: Interventional

The study team will use a pre-post study design, in which data will be collected from 60 patients under "control" conditions (Phase I), whereby an iPad-delivered decision aid is implemented in the clinic to address only standard smoking cessation options (i.e., nicotine replacement therapy and approved prescription medications) with patients who are current smokers. After that, the iPad-delivered decision aid will be implemented with an additional 60 patients for the "intervention" condition (Phase II), whereby the decision aid will also address e-cigarettes, in addition to standard smoking cessation options.